Bispecific Antibodies for the Treatment of Multiple Myeloma

被引：0
|
作者：
Scott R. Goldsmith
Shawn Streeter
Fahrettin Covut
机构：
[1] Judy and Bernard Briskin Center for Multiple Myeloma Research,Division of Oncology
[2] City of Hope Comprehensive Cancer Center,undefined
[3] Washington University School of Medicine,undefined
来源：
Current Hematologic Malignancy Reports | 2022年 / 17卷
关键词：
Bispecific antibodies; Bispecific T-cell engagers; Multiple myeloma; Immunotherapy; BCMA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：286 / 297
页数：11
相关论文
共 50 条
  • [21] T-cell-redirecting bispecific antibodies in multiple myeloma: a revolution?
    Moreau, Philippe
    Touzeau, Cyrille
    BLOOD, 2022, 139 (26) : 3681 - 3687
  • [22] The Role of Bispecific Antibodies in Relapsed Refractory Multiple Myeloma: A Systematic Review
    Khanam, Razwana
    Ashruf, Omer S.
    Bin Waqar, Syed Hamza
    Shah, Zunairah
    Batool, Saba
    Mehreen, Rameesha
    Pachika, Pranali
    Roksana, Zinath
    Rehman, Mohammad Ebad Ur
    Anwer, Faiz
    ANTIBODIES, 2023, 12 (02)
  • [23] The evolving status of immunotherapies in multiple myeloma: the future role of bispecific antibodies
    Swan, Dawn
    Routledge, David
    Harrison, Simon
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (03) : 488 - 506
  • [24] Bispecific Antibodies in Multiple Myeloma: Opportunities to Enhance Efficacy and Improve Safety
    Swan, Dawn
    Murphy, Philip
    Glavey, Siobhan
    Quinn, John
    CANCERS, 2023, 15 (06)
  • [25] Bispecific Antibodies for Multiple Myeloma: Recent Advancements and Strategies for Increasing Their Efficacy
    Wang, Moran
    Wang, Chaofan
    Deng, Jun
    Wang, Huafang
    Sun, Chunyan
    Luo, Shanshan
    Hu, Yu
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2024, 29 (06):
  • [26] Treatment patterns for extramedullary multiple myeloma and outcomes with CAR-T therapy and bispecific antibodies.
    Zanwar, Saurabh
    Ho, Matthew
    Kapoor, Prashant
    Binder, Moritz
    Buadi, Francis
    Dispenzieri, Angela
    Dingli, David
    Fonder, Amie L.
    Gertz, Morie A.
    Gonsalves, Wilson I.
    Hayman, Suzanne R.
    Hwa, Yi Lisa
    Hobbs, Miriam A.
    Kourelis, Taxiarchis
    Lacy, Martha
    Leung, Nelson
    Muchtar, Eli
    Warsame, Rahma M.
    Rajkumar, S. Vincent
    Kumar, Shaji
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] T cell redirecting bispecific antibodies for multiple myeloma: emerging therapeutic strategies in a changing treatment landscape
    Kazandjian, Dickran
    Kowalski, Andrew
    Landgren, Ola
    LEUKEMIA & LYMPHOMA, 2022, 63 (13) : 3032 - 3043
  • [28] T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma: Optimal Dosing Schedule and Duration of Treatment
    van de Donk, Niels W. C. J.
    Rasche, Leo
    Sidana, Surbhi
    Zweegman, Sonja
    Garfall, Alfred L.
    BLOOD CANCER DISCOVERY, 2024, 5 (06): : 388 - 399
  • [29] Emerging antibodies for the treatment of multiple myeloma
    Zagouri, Flora
    Terpos, Evangelos
    Kastritis, Efstathios
    Dimopoulos, Meletios A.
    EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (02) : 225 - 237
  • [30] Monoclonal Antibodies in the Treatment of Multiple Myeloma
    van de Donk, Niels W. C. J.
    Zweegman, Sonja
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (02) : 337 - 360
12345